Drug intelligence / Profile preview

QRu + resveratrol

Development stage
Preclinical
Modality
Nanoparticles → Drug Delivery Systems, Small Molecules
Administration
Intravenous
01

Overview

QRu + resveratrol (specifically formulated as QRu-PLGA-RES-DS NPs) is an experimental core-shell nanocomposite designed for the treatment of rheumatoid arthritis (RA). The system utilizes quadrilateral ruthenium nanoparticles (QRuNPs) as a photothermal core, encapsulated within a thermosensitive shell of poly(lactic-co-glycolic acid) (PLGA) modified with dextran sulfate (DS) for targeted delivery. The nanocarrier improves the water solubility and delivery of resveratrol (RES). Its primary therapeutic mechanism involves inducing the polarization of pro-inflammatory M1-type macrophages into anti-inflammatory M2-type macrophages, thereby eliminating the inflammatory response in RA. Additionally, the QRu nanoparticles enable photoacoustic (PA) imaging for real-time monitoring of drug distribution in inflammatory tissues.

Other names
quadrilateral ruthenium nanoparticles + resveratrolQRu-PLGA-DS NPs
02

Targets

SIRT1 (NAD-dependent protein deacetylase sirtuin-1)NF-κB

Beyond the preview

Go deeper on QRu + resveratrol.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on QRu + resveratrol.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call